Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 10, 2011, Pages 1221-1224

  Berardi, Alberto ^a   Lugli, Licia ^a   Rossi, Cecilia ^a   China, Mariachiara ^a   Chiossi, Claudio ^c   Gambini, Lucia ^d   Guidi, Battista ^c   Pedna, Maria Federica ^e   Piepoli, Marina ^f   Simoni, Angela ^b   Ferrari, Fabrizio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Ospedale B Ramazzini   (Italy)

^c Ospedale Civile   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e Laboratorio di Microbiologia   (Italy)

^f GUGLIELMO DA SALICETO HOSPITAL   (Italy)

Author keywords

Group B streptococcus; Infant; Prophylaxis; Sepsis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD SAMPLING; CEREBROSPINAL FLUID; CESAREAN SECTION; CHILDBIRTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EXPOSURE; DRUG TREATMENT FAILURE; EMERGENCY SURGERY; ESOPHAGUS ATRESIA; FEVER; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFANT; INTRAPARTUM CARE; LOADING DRUG DOSE; MATERNAL CARE; ONSET AGE; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEPSIS; STREPTOCOCCUS AGALACTIAE; SYMPTOMATOLOGY;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; ITALY; PREGNANCY; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT FAILURE;

EID: 80052984995     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.552652     Document Type: Article

References (10)

1. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
2. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77.
3. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-1064.
4. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol 2006;108:1254-1265. (Pubitemid 44665425)
5. Berardi A, Lugli L, Baronciani D, Rossi C, Ciccia M, Creti R, Gambini L, Mariani S, Papa I, Tridapalli E, et al. Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screeningbased approach. Pediatr Infect Dis J 2010;29:115-121.
6. Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991;18:361-381.
7. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-2065. (Pubitemid 351656587)
8. Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, Juni BA, Cieslak PR, Farley MM, Dumas NB, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008;2008: 727505.
9. Blaschke AJ, Pulver LS, Korgenski EK, Savitz LA, Daly JA, Byington CL. Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease. J Pediatr 2010;156:501-503.
10. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626-2636.